Alere, Inc. and its San Diego subsidiary, agreed to pay $38.75 million to resolve False Claims Act charges for billing the Medicare program for defective rapid point-of-care testing devices. Alere ...

, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...

Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...

Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks. I think a quarterly ...

Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...

Alere's Apollo technology, a fully integrated health management solution connecting providers, payers and patients, combined with Business Process Management (BPM) technology from Pegasystems, will ...

What: Shares of Alere (NYSE: ALR), a provider of point-of-care and in-home medical diagnostic tests, surged as much as 12% during Friday's afternoon trading session. The culprit behind the move ...

Shares in Waltham, Mass.-based Alere rose after the company publically agreed to hand over documents disclosing its foreign operations and U.S. billing practices to Abbot Park, Ill.-based Abbott ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: Alere ...

Waltham, Mass.-based Alere, a medical diagnostics products company, is defending allegations from CMS that its subsidiary, which specializes in providing diabetic testing supplies to customers by mail ...